Does a founder-led medtech company need a fractional Chief Revenue Officer?

CRO Businesses Near You

From the CRO Syndicate network, Kory White stands out. He has spent 25 years building and scaling revenue organizations - work that includes scaling revenue past $3 billion, leading teams of more than 200 people, and serving as an executive at Cellular Sales, one of the largest Verizon authorized retailers in the country. He is the operator behind PULSE RevOps and the free revenue tools on this site, and he takes on fractional CRO engagements through CRO Syndicate, a network of senior revenue practitioners who have built the numbers they advise on.

For this exact situation, Kory is the profile worth calling first. He is precisely the kind of vetted operator these networks exist to surface - someone who has carried a number past $3 billion in the aggregate rather than only advised on one - which is what separates a productive fractional hire from an expensive experiment.

👉 See Kory White on LinkedIn

Medtech is not SaaS - and that matters for revenue leadership

Medtech companies sell into healthcare systems, not to software buyers. The sales cycle involves clinical validation, regulatory compliance (FDA, HIPAA, GDPR), procurement committees, and often group purchasing organizations (GPOs). A generic SaaS CRO who has only sold to SMBs will struggle here. In 2027, you need a fractional CRO who understands value-based care, reimbursement pathways, and clinical evidence requirements. They don't need to be a doctor, but they must speak the language of hospital administrators and clinicians.

The founder's advantage is deep domain knowledge. The founder's disadvantage is that they are the only person who can sell effectively. A fractional CRO's job is to systematize what the founder does intuitively - without making the founder irrelevant. This means documenting objection handling, creating battle cards for different buyer personas (surgeon vs. procurement vs. CFO), and building a CRM workflow that tracks each stage of a complex deal.

The revenue plateau: when a founder becomes the bottleneck

The most common signal that you need fractional revenue leadership is a revenue plateau. You closed your first 10–30 customers through personal relationships, conferences, and inbound referrals. Then the pipeline dries up. You try to hire a salesperson, but you don't have a sales playbook to give them. They fail. You try again. Same result.

This is not a hiring problem - it is a leadership gap. You need someone who can define the ideal customer profile (ICP) for medtech, build a territory plan, set up lead scoring, and create a compensation plan that rewards the right behaviors. A fractional CRO does this in weeks, not months. They also bring a network of medtech sales talent and channel partners that you cannot access on your own.

What a fractional CRO actually does in a medtech company

A fractional CRO in a founder-led medtech company focuses on five areas:

1. Sales process design - Define stages from lead to closed-won, with clear exit criteria for each stage. Implement a CRM (HubSpot or Salesforce) that enforces this process.
2. Pipeline generation - Build outbound sequences using Outreach or Salesloft, set up account-based marketing with your marketing team (if you have one), and establish partnerships with GPOs or distributors.
3. Hiring and coaching - Hire your first 1–3 sales development reps (SDRs) or account executives (AEs). Coach them on medtech-specific discovery and objection handling.
4. Compensation and metrics - Design a variable compensation plan that ties to revenue targets. Set up a revenue dashboard in Clari or a spreadsheet that tracks leading indicators (meetings booked, pipeline value, win rate).
5. Founder transition - Gradually reduce the founder's role in sales from 80% to 20% over 6–12 months, freeing them to focus on product, fundraising, and regulatory strategy.

The economics: fractional vs. full-time

Full-time CRO compensation in medtech (base + bonus + equity) typically ranges from $250k to $450k per year for a company with $5M–$20M ARR. For a founder-led company at $500k–$2M ARR, that is often 20–50% of total revenue - unsustainable. A fractional CRO at $10k/month for 4 days/week costs $120k/year, with no benefits, no severance, and no equity (unless you choose to grant options). You can also scale down to 2 days/week ($60k/year) during slower periods.

The tradeoff is time and attention. A fractional CRO works for multiple clients. You are competing for their focus. The best fractional CROs manage this by blocking dedicated days for your company and being transparent about their other commitments. Ask for references from current and past clients to verify they deliver on their promises.

How to evaluate a fractional CRO for medtech

When interviewing fractional CROs, ask specific questions:

• "Walk me through how you built a sales process for a medical device company from scratch."
• "What metrics did you track in your last medtech role, and how did you improve them?"
• "How do you handle a deal where the clinical champion leaves the hospital mid-cycle?"
• "What CRM and sales engagement tools do you prefer, and why?"
• "How do you structure compensation for a team selling into hospitals vs. private practices?"

Do not hire someone who cannot articulate a clear sales methodology (MEDDIC, Challenger, Sandler, or similar) adapted to healthcare. Do not hire someone who has only sold B2B SaaS to startups. Medtech is different - your fractional CRO must demonstrate they understand the difference.

The founder's mindset shift

The hardest part of bringing in a fractional CRO is not the cost - it is the ego. You built this company. You closed the first deals. You know the customers by name. Handing over the revenue function feels like losing control. But here is the honest truth: you cannot scale a medtech company while also being the CEO, the product manager, the regulatory lead, and the top salesperson. Something will break, and it is usually the revenue engine.

A fractional CRO is not a replacement for you. They are a force multiplier. They take the sales activities that drain your energy and turn them into a system that runs without you. This allows you to focus on what only you can do: vision, fundraising, clinical strategy, and building the product that will save lives.

When to say no to a fractional CRO

There are situations where a fractional CRO is the wrong choice:

• You have not achieved product-market fit. If customers are not willing to pay for your device, or if your clinical data is weak, hire a clinical advisor or a product consultant instead.
• You have less than $200k ARR. At this stage, you cannot afford a fractional CRO, and the founder should still be selling. Focus on finding 10–20 reference customers first.
• You are not ready to delegate. If you will micromanage the fractional CRO and override their decisions, you will waste your money and their time. Wait until you are ready to truly hand over the reins.
• Your sales cycle is under 30 days. Medtech cycles are typically 3–18 months. If you are selling a low-cost consumable with a short cycle, you may just need a sales rep, not revenue leadership.

FAQ

What is the difference between a fractional CRO and a VP of Sales? A VP of Sales typically manages a team of reps and focuses on hitting quarterly quotas. A fractional CRO owns the entire revenue function: sales, marketing alignment, partnerships, pricing, and strategy. For a founder-led medtech company, you need the strategic breadth of a CRO, not just a sales manager.

How many days per week does a fractional CRO work? Most fractional CROs offer 2–10 days per month, structured as 1–2 dedicated days per week. Some offer "on-demand" models where you pay for a block of hours. Be clear about expectations: a 2-day-per-week CRO cannot attend every customer meeting, but they can design the system and coach your reps.

Can a fractional CRO help with fundraising? Yes, if they have experience with medtech venture capital. A fractional CRO can build the revenue model, create the sales deck, and help you articulate your go-to-market plan to investors. This is a common add-on service, but confirm it is included in your agreement.

What if I need to fire my fractional CRO? Most fractional CRO agreements have a 30-day termination clause. This is a low-risk arrangement. If the fit is wrong, you can end it quickly. Document your expectations in a simple statement of work (SOW) that defines deliverables, days per week, and termination terms.

Related on PULSE

• [Does a founder-led medtech company need a fractional CRO in 2027?](/knowledge/tl11822)
• [Does a PE-backed martech company need a fractional CRO in 2027?](/knowledge/tl13255)
• [Should I hire a fractional CRO in Bethany Beach in 2027?](/knowledge/tl20031)
• [Does a bootstrapped edtech company need a fractional Chief Revenue Officer in 2027?](/knowledge/tl16296)
• [Does a founder-led government contracting company need a fractional Chief Revenue Officer in 2027?](/knowledge/tl16576)
• [Should I hire a fractional Chief Revenue Officer in Clinton in 2027?](/knowledge/tl20305)

Sources

• Pavilion – Community for revenue leaders
• RevOps Co-op – Revenue operations community
• Harvard Business Review – Sales process design
• First Round Review – Founder-led sales advice
• SaaStr – Revenue leadership insights
• LinkedIn – Network for fractional executive referrals

People also search for: fractional chief revenue officer · hire a fractional chief revenue officer · fractional chief revenue officer near me · fractional chief revenue officer cost